2008
DOI: 10.1111/j.1365-4632.2008.03873.x
|View full text |Cite
|
Sign up to set email alerts
|

Lithium and skin: dermatologic manifestations of lithium therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
27
0

Year Published

2011
2011
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(27 citation statements)
references
References 148 publications
(229 reference statements)
0
27
0
Order By: Relevance
“…Not all patients on lithium treatment will develop exacerbation. Therefore, pre-existing psoriasis is not considered a contraindication to lithium treatment (for a full review of this literature, see [36]). …”
Section: Psoriasismentioning
confidence: 99%
See 2 more Smart Citations
“…Not all patients on lithium treatment will develop exacerbation. Therefore, pre-existing psoriasis is not considered a contraindication to lithium treatment (for a full review of this literature, see [36]). …”
Section: Psoriasismentioning
confidence: 99%
“…Patients with psoriasis have high levels of anxiety, depression, worry and suicidal ideations compared with normal controls [35]. There is another concern for psychiatrists related to lithium-induced psoriasis that may occur in the early years of treatment [36]. Lithium has been implicated in the induction and exacerbation of psoriasis within a few weeks to a few months of initiating lithium therapy.…”
Section: Psoriasismentioning
confidence: 99%
See 1 more Smart Citation
“…Most interestingly, lithium-mediated inhibition of GSK-3 was recently shown to result in increased neutrophil production and release of lysosomal enzymes (19). This effect has been linked with several cutaneous side effects of lithium therapy [reviewed in (20)] and might well account for the development of UD lesions, a prominent hallmark of which is a massive neutrophil infiltration.…”
Section: Discussionmentioning
confidence: 99%
“…Although quantitative meta-analytical estimates did not show an increased rate of skin disorders in lithium-treated patients compared to those given placebo (McKnight et al 2012), there is substantial anecdotic evidence supporting this association. Indeed, some authors indicated that the rate of cutaneous adverse reactions during lithium maintenance therapy might be as high as 45% (Jafferany 2008). Here, firstly we presented a new case of adverse cutaneous reaction during lithium treatment, confirmed by a re-challenge of the drug after its discontinuation.…”
Section: Introductionmentioning
confidence: 99%